
UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
Will a court ruling push the DEA to reschedule psilocybin?
"The obvious gap in the palliative care toolbox is a tool for the relief of nonphysical suffering, and psilocybin is that tool." "It's really essential that everyone in patients' rights, hospice and the palliative care movement stand up and insist that it be available sooner rather than later."
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey
The social acceptability of psilocybin-assisted therapy for existential distress at the end of life is rather high in Canada. These findings may contribute to efforts to mobilise resources and improve access to this emerging therapy in palliative and end of life care settings.
Applying key lessons from the hospice and palliative care movement to inform psychedelic-assisted therapy
The intention of this commentary is to articulate the deep synergies between hospice and palliative care and PAT.
The impact of psychedelic drugs on anxiety and depression in advanced cancer or other life-threatening disease: A systematic review with meta-analysis
Although the results are promising, future trials are needed to assess the optimal psychedelic, dose, number of sessions required.
Psychedelics for patients with cancer: A comprehensive literature review
Psychedelics have a unique mechanism of action that might be well suited for treating anxiety and depression associated with cancer.
'Magic' of psychedelics: Easing the trauma of terminal illness
A growing body of evidence shows that psilocybin is safe and can relieve symptoms of depression and end-of-life demoralization in people with cancer and other life-threatening conditions.